BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15708597)

  • 61. Virus self-assembly proceeds through contact-rich energy minima.
    Buzón P; Maity S; Christodoulis P; Wiertsema MJ; Dunkelbarger S; Kim C; Wuite GJL; Zlotnick A; Roos WH
    Sci Adv; 2021 Nov; 7(45):eabg0811. PubMed ID: 34730996
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Correction to: Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects.
    Vandenbossche J; Jessner W; van den Boer M; Biewenga J; Berke JM; Talloen W; De Zwart L; Snoeys J; Vandyck K; Fry J; Yogaratnam J
    Adv Ther; 2020 Apr; 37(4):1703. PubMed ID: 32133584
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Easy Synthesis of Complex Biomolecular Assemblies: Wheat Germ Cell-Free Protein Expression in Structural Biology.
    Fogeron ML; Lecoq L; Cole L; Harbers M; Böckmann A
    Front Mol Biosci; 2021; 8():639587. PubMed ID: 33842544
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Addressing Antiretroviral Drug Resistance with Host-Targeting Drugs-First Steps towards Developing a Host-Targeting HIV-1 Assembly Inhibitor.
    Lingappa JR; Lingappa VR; Reed JC
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802145
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of an Antiretroviral Small Molecule That Appears To Be a Host-Targeting Inhibitor of HIV-1 Assembly.
    Reed JC; Solas D; Kitaygorodskyy A; Freeman B; Ressler DTB; Phuong DJ; Swain JV; Matlack K; Hurt CR; Lingappa VR; Lingappa JR
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33148797
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthesis and Assembly of Hepatitis B Virus-Like Particles in a
    Spice AJ; Aw R; Bracewell DG; Polizzi KM
    Front Bioeng Biotechnol; 2020; 8():72. PubMed ID: 32117947
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combining Cell-Free Protein Synthesis and NMR Into a Tool to Study Capsid Assembly Modulation.
    Wang S; Fogeron ML; Schledorn M; Dujardin M; Penzel S; Burdette D; Berke JM; Nassal M; Lecoq L; Meier BH; Böckmann A
    Front Mol Biosci; 2019; 6():67. PubMed ID: 31440516
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Host Cell Rab GTPases in Hepatitis B Virus Infection.
    Zeyen L; Prange R
    Front Cell Dev Biol; 2018; 6():154. PubMed ID: 30510928
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatitis B Virus Subverts the Autophagy Elongation Complex Atg5-12/16L1 and Does Not Require Atg8/LC3 Lipidation for Viral Maturation.
    Döring T; Zeyen L; Bartusch C; Prange R
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367244
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Design of virus-based nanomaterials for medicine, biotechnology, and energy.
    Wen AM; Steinmetz NF
    Chem Soc Rev; 2016 Jul; 45(15):4074-126. PubMed ID: 27152673
    [TBL] [Abstract][Full Text] [Related]  

  • 71. How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.
    Lingappa JR; Reed JC; Tanaka M; Chutiraka K; Robinson BA
    Virus Res; 2014 Nov; 193():89-107. PubMed ID: 25066606
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Host-rabies virus protein-protein interactions as druggable antiviral targets.
    Lingappa UF; Wu X; Macieik A; Yu SF; Atuegbu A; Corpuz M; Francis J; Nichols C; Calayag A; Shi H; Ellison JA; Harrell EK; Asundi V; Lingappa JR; Prasad MD; Lipkin WI; Dey D; Hurt CR; Lingappa VR; Hansen WJ; Rupprecht CE
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E861-8. PubMed ID: 23404707
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Testing an electrostatic interaction hypothesis of hepatitis B virus capsid stability by using an in vitro capsid disassembly/reassembly system.
    Newman M; Chua PK; Tang FM; Su PY; Shih C
    J Virol; 2009 Oct; 83(20):10616-26. PubMed ID: 19656897
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assembly of immature HIV-1 capsids using a cell-free system.
    Lingappa JR; Thielen BK
    Methods Mol Biol; 2009; 485():185-95. PubMed ID: 19020826
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.
    Puro R; Schneider RJ
    J Virol; 2007 Jul; 81(14):7351-62. PubMed ID: 17475655
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparing capsid assembly of primate lentiviruses and hepatitis B virus using cell-free systems.
    Lingappa JR; Newman MA; Klein KC; Dooher JE
    Virology; 2005 Mar; 333(1):114-23. PubMed ID: 15708597
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cell-free systems for capsid assembly of primate lentiviruses from three different lineages.
    Dooher JE; Lingappa JR
    J Med Primatol; 2004 Oct; 33(5-6):272-80. PubMed ID: 15525328
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly.
    Klein KC; Polyak SJ; Lingappa JR
    J Virol; 2004 Sep; 78(17):9257-69. PubMed ID: 15308720
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Conservation of a stepwise, energy-sensitive pathway involving HP68 for assembly of primate lentivirus capsids in cells.
    Dooher JE; Lingappa JR
    J Virol; 2004 Feb; 78(4):1645-56. PubMed ID: 14747530
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Envelopment of the hepatitis B virus nucleocapsid.
    Bruss V
    Virus Res; 2004 Dec; 106(2):199-209. PubMed ID: 15567498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.